A Phase 1 Trial of Cabazitaxel Combined With 188 Re–Hydroxyethylidene Diphosphonate in Patients With Metastatic Castration-Resistant Prostate Cancer Who Progressed on or After a Docetaxel-Containing Treatment: The ReCab Trial

Authors :: MS Medische Oncologie
Cancer
van Dodewaard-de Jong, Joyce M.
Bouman-Wammes, Esther W.
Bloemendal, Haiko J.
Verheul, Henk M W
de Klerk, John M H
van den Eertwegh, Alfons J M
MS Medische Oncologie
Cancer
van Dodewaard-de Jong, Joyce M.
Bouman-Wammes, Esther W.
Bloemendal, Haiko J.
Verheul, Henk M W
de Klerk, John M H
van den Eertwegh, Alfons J M
Publication Year :: 2017

Tools